Does ENZALUTAMIDE Cause Atrial fibrillation? 303 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 303 reports of Atrial fibrillation have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.6% of all adverse event reports for ENZALUTAMIDE.
303
Reports of Atrial fibrillation with ENZALUTAMIDE
0.6%
of all ENZALUTAMIDE reports
43
Deaths
174
Hospitalizations
How Dangerous Is Atrial fibrillation From ENZALUTAMIDE?
Of the 303 reports, 43 (14.2%) resulted in death, 174 (57.4%) required hospitalization, and 12 (4.0%) were considered life-threatening.
Is Atrial fibrillation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 303 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Atrial fibrillation?
APIXABAN (5,690)
IBRUTINIB (3,671)
LENALIDOMIDE (2,704)
RITUXIMAB (2,100)
SACUBITRIL\VALSARTAN (2,062)
RIVAROXABAN (2,027)
ADALIMUMAB (1,709)
METOPROLOL (1,462)
DEXAMETHASONE (1,461)
METHOTREXATE (1,411)
Which ENZALUTAMIDE Alternatives Have Lower Atrial fibrillation Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE